Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase 3, double-blind, placebo-controlled, randomised trial

Francisco M. Marty, Per Ljungman, Genovefa A. Papanicolaou, Drew J. Winston, Roy F. Chemaly, Lynne Strasfeld, Jo Anne H. Young, Tulio Rodriguez, Johan Maertens, Michael Schmitt, Hermann Einsele, Augustin Ferrant, Jeffrey H. Lipton, Stephen A. Villano, Hongzi Chen, Michael Boeckh

Research output: Contribution to journal › Article › peer-review

295 Scopus citations

Fingerprint

Dive into the research topics of 'Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: A phase 3, double-blind, placebo-controlled, randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences